Sulindac Prevents Carcinogen-Induced Intrahepatic Cholangiocarcinoma Formation In Vivo

« Previous Next »Journal of Surgical Research
Volume 157, Issue 1 , Pages e87-e95, November 2009

Sabrina C. Wentz, M.D.
- Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
Michele T. Yip-Schneider, Ph.D.
- Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
- Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana
Earl A. Gage, M.D.
- Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
Romil Saxena, M.D.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
Sunil Badve, M.D.
- Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana
C. Max Schmidt, M.D., Ph.D.
- Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana
- Indiana University Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana
- Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana
- Walther Oncology Center, Indiana University School of Medicine, Indianapolis, Indiana
- Richard L. Roudebush VAMC, Indiana University School of Medicine, Indianapolis, Indiana
- To whom correspondence and reprint requests should be addressed at Departments of Surgery and Biochemistry, Cancer Research Institute, Molecular Biology, 1044 W Walnut St. R4-039, Indianapolis, IN 46202.